VISION event

Vision Strategy Board

  • Richard Alldread, CPI
  • Tony Bradshaw, KTN (Chair)
  • Crawford Brown, Actavis Biologics
  • Barry Buckland, BiologicB
  • Andrew Davidson, Consultant
  • Suzy Farid, UCL Biochemical Engineering
  • Richard Francis, Francis Biopharma
  • Gunter Jagschies, GE
  • Eli Keshavarz-Mooore, UCL Biochemical Engineering
  • Peter Levison, PALL
  • Jim Mills, Cantab Biopharmaceuticals 
  • Tarit Mukhopadhyay, UCL Biochemical Engineering
  • Michelle Scott, Unicorn Biologics
  • Karen Smith, UCL Biochemical Engineering
  • Stuart Thompson, IP Group
  • David Venables, Anatara Life Sciences
  • Stephen Ward, Cell Therapy Catapult
  • Amanda Weiss, Fujifilm Diosynth Biotechnologies


  • Steve Arlington, PriceWaterhouseCoopers
  • Barry Buckland, BiologicB
  • Gunter Jagschies, GE Healthcare
  • Jo Pisani, PriceWaterhouseCoopers
  • Martyn Postle, Cambridge Healthcare & Biotech
  • Alain Pralong, GSK
  • Andrew Ramelmeier, BioMarin
  • Vicki Salmon, IP Asset Ventures
  • Michelle Scott, Scott Biopharm Limited
  • Rahul Singhvi, Takeda Vaccines

Academic staff


In order to provide the best possible range of leading-edge experts, we have drawn from our own world-class faculty and from the faculties within the wider University of London community such as EPSRC Centre for Innovative Manufacturing in Emerging Macromolecular Therapies. All are recognised and respected internationally and work closely with high-profile organisations across a broad range of industries.


VISION partners

Page last modified on 21 may 14 12:57